Advantage of accelerated fractionation regimens in definitive radiotherapy for stage II glottic carcinoma

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 10, 2006, Pages 727-732

  Nomiya, Takuma ^a   Nemoto, Kenji ^a   Wada, Hitoshi ^a   Takai, Yoshihiro ^a   Yamada, Shogo ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Accelerated fractionation; Glottic carcinoma; Overall treatment time; Radiotherapy; T2 cancer; Total dose

Indexed keywords

CARBOPLATIN; CISPLATIN; COBALT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; HUMAN; INTERMETHOD COMPARISON; LARYNGITIS; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION HAZARD; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT DURATION;

EID: 33750035804     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611501003     Document Type: Article

References (16)

1. Kaplan MJ, Johns ME, Clark DA, Cantrell RW. Glottic carcinoma. The roles of surgery and irradiation. Cancer 1984;53:2641-8.
2. Chatani M, Matayoshi Y, Masaki N. Radiation therapy for larynx carcinoma: long-term results of stage I glottic carcinoma. Strahlenther Onkol 1993;169:102-6.
3. Mendenhall WM, Parsons JT, Million RR, Fletcher GH. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 1988;15:1267-73.
4. Slevin NJ, Hendry JH, Roberts SA, Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992;24:215-20.
5. [Erratum in Radiother Oncol 1992;25:227.]
6. Smee R, Bridger GP, Williams J, Fisher R. Early glottic carcinoma: results of treatment by radiotherapy. Australas Radiol 2000;44:53-9.
7. Harwood AR, DeBoer G. Prognostic factors in T2 glottic cancer. Cancer 1980;45:991-5.
8. Sobin LH, Wittekind C, eds. TNM classification of malignant tumors. 5th ed. New York, NY: Wiley-Liss, 1997.
9. Common toxicity criteria version 2.0. Common toxicity criteria manual. Bethesda, Md: National Cancer Institute, June 1, 1999.
10. Le QT, Fu KK, Kroll S, et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997;39:115-26.
11. Sakata K, Aoki Y, Karasawa K, et al. Radiation therapy in early glottic carcinoma: uni- and multivariate analysis of prognostic factors affecting local control. Int J Radiat Oncol Biol Phys 1994;30:1059-64.
12. Kitano M, Nishiguchi I, Aoki Y, et al. Relation between overall treatment time and local control of early glottic laryngeal cancer: comparison of six versus five times per week [in Japanese]. Nippon Igaku Hoshasen Gakkai Zasshi 2002;62:366-9.
13. Fein DA, Lee WR, Hanlon AL, Ridge JA, Curran WJ, Coia LR. Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx? Int J Radiat Oncol Biol Phys 1996;34:823-31.
14. Krawczyk J, Svoboda V, Foster L. The influence of some factors on local control of early glottic cancer. Clin Oncol (R Coll Radiol) 1991;3:330-4.
15. Nishimura Y, Nagata Y, Okajima K, et al. Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control. Radiother Oncol 1996;40:225-32.
16. Ricciardelli EJ, Weymuller EA Jr, Koh WJ, Austin-Seymour M, DeSautel MG, Laramore GE. Effect of radiation fraction size on local control rates for early glottic carcinoma. A model analysis for in vivo tumor growth and radio-response parameters. Arch Otolaryngol Head Neck Surg 1994;120:737-42.